Avira Pharmaceuticals Private Limited
About Avira Pharmaceuticals Private Limited
Data last updated:
Avira Pharmaceuticals Private Limited is a private limited company based in Gurgaon, Haryana, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 28 November 2023.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U21002HR2023PTC116788.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Poonam and Vinay.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sector 78, Gurgaon, Haryana.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.51 Lakh. For the same year it recorded a net loss of ₹1.01 Lakh (net margin -15.5%) and EBITDA of -₹1.01 Lakh (EBITDA margin -15.5%).
Company details
Contact details
Avira Pharmaceuticals Private Limited's registered office is in Gurgaon, Haryana.
- Registered AddressShop No. 18 First Floor Master Phelad Singh Bhawan, Naurangpur More Sector 78, Gurgaon, Haryana, India – 122004
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Avira Pharmaceuticals Private Limited
FY 2025 filings availableAvira Pharmaceuticals Private Limited reported revenue of ₹6.51 Lakh for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹1.01 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹1.01 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -15.5% | |
| Net Profit Margin | -15.5% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Avira Pharmaceuticals Private Limited, buy the company report.
Board of directors of Avira Pharmaceuticals Private Limited
Avira Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Peer comparison
Avira Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| H.L. Pharmaceuticals Private Limited | ₹6.54 Lakh (FY 2025) | 15.0% | Kolkata, West Bengal, India | |||
| Anthill Pharmaceuticals Private Limited | ₹6.54 Lakh (FY 2018) | Gorakhpur, Uttar Pradesh, India | ||||
| St. Sharma's Pharmaceuticals & Chemical Industries Private Limited | ₹6.54 Lakh (FY 2025) | 20.0% | Kolkata, West Bengal, India | |||
| Jash Pharmaceuticals and Medical Supplies Private Limited | ₹6.52 Lakh (FY 2025) | -4.0% | Chennai, Tamil Nadu, India | |||
| Seignior Pharmaceuticals Private Limited | ₹6.51 Lakh (FY 2024) | -36.0% | Cuttack, Odisha, India | |||
| Avira Pharmaceuticals Private Limitedthis company | ₹6.51 Lakh (FY 2025) | -₹1.01 Lakh | -15.5% | Gurgaon, Haryana, India | ||
| Trams Pharmaceuticals Private Limited | ₹6.5 Lakh (FY 2024) | -11.0% | Pune, Maharashtra, India | |||
| Pradocia Pharmaceuticals Private Limited | ₹6.49 Lakh (FY 2020) | 252.0% | Pune, Maharashtra, India | |||
| Inpra Pharmaceuticals Private Limited | ₹6.49 Lakh (FY 2020) | 147.0% | Mumbai, Maharashtra, India | |||
| Genoclone Pharmaceuticals Private Limited | ₹6.48 Lakh (FY 2025) | Ghaziabad, Uttar Pradesh, India | ||||
| Define Pharmaceuticals Private Limited | ₹6.46 Lakh (FY 2025) | 3.0% | Ranpur, Odisha, India |
To see the full peer comparison of Avira Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Avira Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Avira Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Avira Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Avira Pharmaceuticals Private Limited has 4 board changes on record since 2023: 3 appointments and 1 cessation. The latest: Prabhat Kumar Singh ceased to be Director on 05 Dec 2025.
Frequently asked questions
Avira Pharmaceuticals is an active private limited company based in Gurgaon, Haryana, India. The company works in paper and paper products, within the paper industry. It was incorporated on 28 November 2023 (3+ years old) and is registered under CIN U21002HR2023PTC116788.
The latest financial statements of Avira Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Avira Pharmaceuticals is U21002HR2023PTC116788. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Avira Pharmaceuticals was incorporated on 28 November 2023, making it 3+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Avira Pharmaceuticals by revenue are H.L. Pharmaceuticals Private Limited, Anthill Pharmaceuticals Private Limited, St. Sharma's Pharmaceuticals & Chemical Industries Private Limited, Jash Pharmaceuticals and Medical Supplies Private Limited, Seignior Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Prabhat Kumar Singh ceased to be Director on 05 Dec 2025. Poonam was appointed as Director on 28 Nov 2023. Prabhat Kumar Singh was appointed as Director on 28 Nov 2023. Avira Pharmaceuticals has 4 board changes on record in total.
The registered office of Avira Pharmaceuticals is at Shop No. 18 First Floor Master Phelad Singh Bhawan, Naurangpur More Sector 78, Gurgaon, Haryana, India – 122004.
Avira Pharmaceuticals operates in the paper industry, in the paper and paper products segment.
Avira Pharmaceuticals can be reached at its registered office: Shop No. 18 First Floor Master Phelad Singh Bhawan, Naurangpur More Sector 78, Gurgaon, Haryana, India – 122004.
Avira Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
